Frazier Healthcare Ventures dropped a line in some solitary waters when it committed a $7 million private investment in publicly traded Endocare Inc.
It’s not unusual for venture capital firms to fish public markets for investments. But biopharmaceutical companies almost always are the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?